市場調査レポート
商品コード
1181655

妊活サプリメントの世界市場 - 見通しと予測(2022年~2027年)

Fertility Supplements Market - Global Outlook & Forecast 2022-2027

出版日: | 発行: Arizton Advisory & Intelligence | ページ情報: 英文 295 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.52円
妊活サプリメントの世界市場 - 見通しと予測(2022年~2027年)
出版日: 2023年01月10日
発行: Arizton Advisory & Intelligence
ページ情報: 英文 295 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の妊活サプリメントの市場規模は、2022年~2027年にCAGRで7.68%の成長が予測されています。妊娠の健康についての意識の高まり、先進国と新興国の市場における高齢妊娠人口の増加、世界中での不妊夫婦の急増、世界の成人における不妊問題の認識といった要因が、市場を後押ししています。

当レポートでは、世界の妊活サプリメント市場について調査分析し、市場規模と予測、促進要因、競合情勢などを提供しています。

目次

第1章 調査手法

第2章 調査目的

第3章 調査プロセス

第4章 範囲

第5章 レポートの前提条件と注意事項

第6章 市場の概要

第7章 イントロダクション

第8章 主要考察

第9章 市場機会と動向

第10章 市場の成長促進要因

第11章 市場抑制要因

第12章 市場情勢

  • 市場の概要
    • 考察:地域別
    • 考察:購入チャネル別
    • 考察:形態別
    • 考察:タイプ別
    • 考察:性別
  • 市場規模と予測
  • ファイブフォース分析

第13章 形態

  • 市場のスナップショットと成長エンジン
  • 市場の概要
  • 天然
  • 合成・ブレンド

第14章 タイプ

  • 市場のスナップショットと成長エンジン
  • 市場の概要
  • カプセル
  • 錠剤
  • ソフトジェル
  • 粉末
  • 液体

第15章 性別

  • 市場のスナップショットと成長エンジン
  • 市場の概要
  • 女性
  • 男性

第16章 購入チャネル

  • 市場のスナップショットと成長エンジン
  • 市場の概要
  • 店頭(OTC)
  • 処方

第17章 地域

  • 市場のスナップショットと成長エンジン
  • 地理的概要

第18章 欧州

  • 市場の概要
  • 市場規模と予測
  • 形態
  • タイプ
  • 性別
  • 購入チャネル
  • 主要国
    • イタリア:市場規模と予測
    • スペイン:市場規模と予測
    • ドイツ:市場規模と予測
    • 英国:市場規模と予測
    • フランス:市場規模と予測

第19章 北米

  • 市場の概要
  • 市場規模と予測
  • 形態
  • タイプ
  • 性別
  • 購入チャネル
  • 主要国
    • 米国:市場規模と予測
    • カナダ:市場規模と予測

第20章 アジア太平洋

  • 市場の概要
  • 市場規模と予測
  • 形態
  • タイプ
  • 性別
  • 購入チャネル
  • 主要国
    • 日本:市場規模と予測
    • 中国:市場規模と予測
    • インド:市場規模と予測
    • 韓国:市場規模と予測
    • オーストラリア:市場規模と予測

第21章 ラテンアメリカ

  • 市場の概要
  • 市場規模と予測
  • 形態
  • タイプ
  • 性別
  • 購入チャネル
  • 主要国
    • ブラジル:市場規模と予測
    • メキシコ:市場規模と予測
    • アルゼンチン:市場規模と予測

第22章 中東・アフリカ

  • 市場の概要
  • 市場規模と予測
  • 形態
  • タイプ
  • 性別
  • 購入チャネル
  • 主要国
    • トルコ:市場規模と予測
    • サウジアラビア:市場規模と予測
    • 南アフリカ:市場規模と予測
    • アラブ首長国連邦:市場規模と予測

第23章 競合情勢

  • 競合の概要
  • 市場シェア分析
    • COAST SCIENCE
    • EXELTIS USA
    • FAIRHAVEN HEALTH
    • LENUS PHARMA GESMBH
    • VITABIOTICS

第24章 主要企業プロファイル

  • COAST SCIENCE
  • EXELTIS USA
  • FAIRHAVEN HEALTH
  • LENUS PHARMA GESMBH
  • VITABIOTICS

第25章 その他の著名なベンダー

  • ADVACARE PHARMA
  • BAYER AG
  • BELI
  • CADI - CAMBRIDGE DIAGNOSTIC IMAGING
  • CARLSON LABS
  • DCMG LABORATORIES
  • ELAN HEALTHCARE
  • EU NATURAL
  • FERMENTA BIOTECH
  • FULLWELL
  • HERA (HERANOW)
  • INOVA PHARMACEUTICALS (PTY) LTD.
  • LABORATORIOS FERTYPHARM S.L.
  • LIFE EXTENSION
  • NESTLE
  • NATURE'S CRAFT
  • NUTRA BUSINESS
  • NUA FERTILITY
  • OCEAN HEALTHCARE
  • ORTHOMOL
  • OVATERRA
  • PRAGATI BIOCARE PVT. LTD.
  • PREMAMA
  • PURITAN'S PRIDE
  • RITUAL
  • RENOVA NUTRITION
  • SUPPLEMENA
  • SEEKING HEALTH
  • TTK
  • THORNE
  • WELLBEING NUTRITION
  • ZENITH NUTRITION

第26章 レポートサマリー

  • 重要事項
  • 戦略的推奨事項

第27章 定量的要約

第28章 付録

図表

LIST OF EXHIBITS

  • EXHIBIT 1 SEGMENTATION OF GLOBAL FERTILITY SUPPLEMENTS MARKET
  • EXHIBIT 2 MARKET SIZE CALCULATION APPROACH 2021
  • EXHIBIT 3 DISTRIBUTION OF REGION BY SIGNIFICANT GAPS IN FERTILITY RATE (2020)
  • EXHIBIT 4 GLOBAL BIRTH RATE PER WOMAN & ANNUAL % CHANGE 2000-2021
  • EXHIBIT 5 GLOBAL FERTILITY RATE BY AGE GROUP 2020
  • EXHIBIT 6 GLOBAL FERTILITY SUPPLEMENTS MARKET SEGMENTATION
  • EXHIBIT 7 IMPACT OF ADVANCES, RESEARCH, & CREDIBILITY IN FERTILITY SUPPLEMENTS
  • EXHIBIT 8 IMPACT OF INCREASE IN PRODUCT LAUNCHES
  • EXHIBIT 9 IMPACT OF FOCUS ON NATURAL FERTILITY SUPPLEMENTS
  • EXHIBIT 10 BENEFITS OF PLANT-DERIVED FERTILITY SUPPLEMENTS
  • EXHIBIT 11 IMPACT OF INCREASE IN PREVALENCE OF INFERTILITY RATE
  • EXHIBIT 12 TOTAL FERTILITY RATE BY REGION, ESTIMATES, AND PROJECTIONS BETWEEN 1950 AND 2100
  • EXHIBIT 13 COUNTRIES WITH HIGHEST REDUCTION IN FERTILITY RATE BETWEEN 2010 AND 2019
  • EXHIBIT 14 IMPACT OF INCREASE IN GOVERNMENT & PUBLIC INITIATIVES FOR FERTILITY AWARENESS
  • EXHIBIT 15 IMPACT OF TREND OF DELAYED PREGNANCIES
  • EXHIBIT 16 IMPACT OF LACK OF AWARENESS & LOW ACCESS TO FERTILITY TREATMENTS IN EMERGING MARKETS
  • EXHIBIT 17 FACTORS HAMPERING INFERTILITY CARE IN EMERGING COUNTRIES
  • EXHIBIT 18 IMPACT OF SIDE EFFECTS RELATED TO FERTILITY SUPPLEMENTS
  • EXHIBIT 19 PROBLEMS ASSOCIATED WITH FERTILITY SUPPLEMENTS PRODUCTS
  • EXHIBIT 20 COMMON SIDE EFFECTS OF FERTILITY SUPPLEMENTS IN WOMEN
  • EXHIBIT 21 IMPACT OF PRESENCE OF ALTERNATIVES TO FERTILITY SUPPLEMENTS
  • EXHIBIT 22 ALTERNATIVE FOR FERTILITY SUPPLEMENTS
  • EXHIBIT 23 GLOBAL FERTILITY SUPPLEMENTS MARKET BY GEOGRAPHY: MARKET SHARE 2021 & 2027
  • EXHIBIT 24 GLOBAL FERTILITY SUPPLEMENTS MARKET BY PURCHASE CHANNEL: MARKET SHARE 2021 & 2027
  • EXHIBIT 25 GLOBAL FERTILITY SUPPLEMENTS MARKET BY FORM: MARKET SHARE 2021 & 2027
  • EXHIBIT 26 GLOBAL FERTILITY SUPPLEMENTS MARKET BY TYPE: MARKET SHARE 2021 & 2027
  • EXHIBIT 27 GLOBAL FERTILITY SUPPLEMENTS MARKET BY GENDER: MARKET SHARE 2021 & 2027
  • EXHIBIT 28 GLOBAL FERTILITY SUPPLEMENTS MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 29 FIVE FORCES ANALYSIS 2021
  • EXHIBIT 30 INCREMENTAL GROWTH BY FORM 2021 & 2027
  • EXHIBIT 31 GLOBAL FERTILITY SUPPLEMENTS MARKET BY FORM 2021-2027
  • EXHIBIT 32 GLOBAL FERTILITY SUPPLEMENTS MARKET BY FORM: OVERVIEW
  • EXHIBIT 33 GLOBAL FERTILITY SUPPLEMENTS MARKET BY FORM: INCREMENTAL GROWTH
  • EXHIBIT 34 GLOBAL FERTILITY SUPPLEMENTS MARKET BY FORM: ABSOLUTE GROWTH
  • EXHIBIT 35 GLOBAL FERTILITY SUPPLEMENTS MARKET BY NATURAL FORM: INCREMENTAL GROWTH & ABSOLUTE GROWTH
  • EXHIBIT 36 GLOBAL FERTILITY SUPPLEMENTS MARKET BY NATURAL FORM 2021-2027 ($ MILLION)
  • EXHIBIT 37 GLOBAL FERTILITY SUPPLEMENTS MARKET BY SYNTHETIC & BLEND FORM: INCREMENTAL GROWTH & ABSOLUTE GROWTH
  • EXHIBIT 38 GLOBAL FERTILITY SUPPLEMENTS MARKET BY SYNTHETIC & BLEND FORM 2021-2027 ($ MILLION)
  • EXHIBIT 39 INCREMENTAL GROWTH BY TYPE 2021 & 2027
  • EXHIBIT 40 GLOBAL FERTILITY SUPPLEMENTS MARKET BY TYPE 2021-2027
  • EXHIBIT 41 GLOBAL FERTILITY SUPPLEMENTS MARKET BY TYPE: OVERVIEW
  • EXHIBIT 42 GLOBAL FERTILITY SUPPLEMENTS MARKET BY TYPE: INCREMENTAL GROWTH
  • EXHIBIT 43 GLOBAL FERTILITY SUPPLEMENTS MARKET BY TYPE: ABSOLUTE GROWTH
  • EXHIBIT 44 GLOBAL FERTILITY SUPPLEMENTS MARKET BY CAPSULE: INCREMENTAL GROWTH & ABSOLUTE GROWTH
  • EXHIBIT 45 BENEFITS OF CAPSULE FORM FERTILITY SUPPLEMENT PRODUCTS
  • EXHIBIT 46 GLOBAL FERTILITY SUPPLEMENTS MARKET BY CAPSULE 2021-2027 ($ MILLION)
  • EXHIBIT 47 GLOBAL FERTILITY SUPPLEMENTS MARKET BY TABLET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
  • EXHIBIT 48 GLOBAL FERTILITY SUPPLEMENTS MARKET BY TABLET 2021-2027 ($ MILLION)
  • EXHIBIT 49 GLOBAL FERTILITY SUPPLEMENTS MARKET BY SOFT GEL: INCREMENTAL GROWTH & ABSOLUTE GROWTH
  • EXHIBIT 50 GLOBAL FERTILITY SUPPLEMENTS MARKET BY SOFT GEL 2021-2027 ($ MILLION)
  • EXHIBIT 51 GLOBAL FERTILITY SUPPLEMENTS MARKET BY POWDER: INCREMENTAL GROWTH & ABSOLUTE GROWTH
  • EXHIBIT 52 GLOBAL FERTILITY SUPPLEMENTS MARKET BY POWDER TYPE 2021-2027 ($ MILLION)
  • EXHIBIT 53 GLOBAL FERTILITY SUPPLEMENTS MARKET BY LIQUID: INCREMENTAL GROWTH & ABSOLUTE GROWTH
  • EXHIBIT 54 GLOBAL FERTILITY SUPPLEMENTS MARKET BY LIQUID 2021-2027 ($ MILLION)
  • EXHIBIT 55 INCREMENTAL GROWTH BY GENDER 2021 & 2027
  • EXHIBIT 56 GLOBAL FERTILITY SUPPLEMENTS MARKET BY GENDER 2021-2027
  • EXHIBIT 57 INFERTILITY: CAUSES & STATISTICS
  • EXHIBIT 58 GLOBAL FERTILITY SUPPLEMENTS MARKET BY GENDER: OVERVIEW
  • EXHIBIT 59 INFERTILITY CAUSING FACTORS & TYPES
  • EXHIBIT 60 GLOBAL FERTILITY SUPPLEMENTS MARKET BY GENDER: INCREMENTAL GROWTH
  • EXHIBIT 61 GLOBAL FERTILITY SUPPLEMENTS MARKET BY GENDER: ABSOLUTE GROWTH
  • EXHIBIT 62 GLOBAL LIVE BIRTHS PER WOMAN BETWEEN 1990 AND 2019
  • EXHIBIT 63 FEMALE INFERTILITY RATE BY AGE GROUP IN 2021 (%)
  • EXHIBIT 64 GLOBAL FERTILITY SUPPLEMENTS MARKET BY WOMEN: INCREMENTAL GROWTH & ABSOLUTE GROWTH
  • EXHIBIT 65 GLOBAL FERTILITY SUPPLEMENTS MARKET BY WOMEN 2021-2027 ($ MILLION)
  • EXHIBIT 66 MALE FERTILITY SUPPLEMENT BENEFITS
  • EXHIBIT 67 INFERTILITY-CAUSING DISORDERS IN MALES
  • EXHIBIT 68 GLOBAL FERTILITY SUPPLEMENTS MARKET BY MEN: INCREMENTAL GROWTH & ABSOLUTE GROWTH
  • EXHIBIT 69 TOP INGREDIENTS IN MALE FERTILITY SUPPLEMENTS
  • EXHIBIT 70 GLOBAL FERTILITY SUPPLEMENTS MARKET BY MEN 2021-2027 ($ MILLION)
  • EXHIBIT 71 INCREMENTAL GROWTH BY PURCHASE CHANNEL 2021 & 2027
  • EXHIBIT 72 GLOBAL FERTILITY SUPPLEMENTS MARKET BY PURCHASE CHANNEL 2021-2027
  • EXHIBIT 73 GLOBAL FERTILITY SUPPLEMENTS MARKET BY PURCHASE CHANNEL: OVERVIEW
  • EXHIBIT 74 GLOBAL FERTILITY SUPPLEMENTS MARKET BY PURCHASE CHANNEL: INCREMENTAL GROWTH
  • EXHIBIT 75 GLOBAL FERTILITY SUPPLEMENTS MARKET BY PURCHASE CHANNEL: ABSOLUTE GROWTH
  • EXHIBIT 76 GLOBAL FERTILITY SUPPLEMENTS MARKET BY OVER-THE-COUNTER (OTC): INCREMENTAL GROWTH & ABSOLUTE GROWTH
  • EXHIBIT 77 GLOBAL FERTILITY SUPPLEMENTS MARKET BY OVER-THE-COUNTER (OTC) SEGMENT 2021-2027 ($ MILLION)
  • EXHIBIT 78 GLOBAL FERTILITY SUPPLEMENTS MARKET BY PRESCRIPTION: INCREMENTAL GROWTH & ABSOLUTE GROWTH
  • EXHIBIT 79 GLOBAL FERTILITY SUPPLEMENTS MARKET BY PRESCRIPTION 2021-2027 ($ MILLION)
  • EXHIBIT 80 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
  • EXHIBIT 81 GLOBAL FERTILITY SUPPLEMENTS MARKET BY GEOGRAPHY
  • EXHIBIT 82 GLOBAL FERTILITY SUPPLEMENTS MARKET BY GEOGRAPHY: OVERVIEW
  • EXHIBIT 83 GLOBAL FERTILITY SUPPLEMENTS MARKET BY GEOGRAPHY: INCREMENTAL GROWTH
  • EXHIBIT 84 GLOBAL FERTILITY SUPPLEMENTS MARKET BY GEOGRAPHY: ABSOLUTE GROWTH
  • EXHIBIT 85 FERTILITY RATE BY AGE GROUP OF MOTHERS IN EUROPE IN YEARS 2001, 2010, & 2019
  • EXHIBIT 86 EUROPE FERTILITY SUPPLEMENTS MARKET: KEY COUNTRIES (2021)
  • EXHIBIT 87 GLOBAL FERTILITY SUPPLEMENTS MARKET IN EUROPE: INCREMENTAL GROWTH & ABSOLUTE GROWTH
  • EXHIBIT 88 EUROPE FERTILITY SUPPLEMENTS MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 89 INCREMENTAL GROWTH IN EUROPE 2021 & 2027
  • EXHIBIT 90 FERTILITY SUPPLEMENTS MARKET IN ITALY 2021-2027 ($ MILLION)
  • EXHIBIT 91 SPAIN: INFERTILITY PREVALENCE
  • EXHIBIT 92 FERTILITY SUPPLEMENTS MARKET IN SPAIN2021-2027 ($ MILLION)
  • EXHIBIT 93 FERTILITY RATE IN GERMANY 2016-2020 (BIRTH RATE PER WOMAN)
  • EXHIBIT 94 GERMANY BIRTH RATE BY AGE GROUP 2020 (PER 1,000 WOMEN)
  • EXHIBIT 95 BIRTH RATE PER YEAR IN GERMANY 2016-2020
  • EXHIBIT 96 FERTILITY SUPPLEMENTS MARKET IN GERMANY 2021-2027 ($ MILLION)
  • EXHIBIT 97 FERTILITY RATE IN UK BY AGE GROUP (LIVE BIRTHS PER 1000 WOMEN)
  • EXHIBIT 98 FERTILITY SUPPLEMENTS MARKET IN THE UK 2021-2027 ($ MILLION)
  • EXHIBIT 99 FRANCE PROJECTED & ESTIMATED FERTILITY RATE 2015-2022 (BIRTHS PER WOMAN)
  • EXHIBIT 100 FERTILITY SUPPLEMENTS MARKET IN FRANCE 2021-2027 ($ MILLION)
  • EXHIBIT 101 NORTH AMERICA FERTILITY SUPPLEMENTS MARKET: KEY COUNTRIES (2021)
  • EXHIBIT 102 GLOBAL FERTILITY SUPPLEMENTS MARKET IN NORTH AMERICA: INCREMENTAL GROWTH & ABSOLUTE GROWTH
  • EXHIBIT 103 NORTH AMERICA FERTILITY SUPPLEMENTS MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 104 INCREMENTAL GROWTH IN NORTH AMERICA 2021 & 2027
  • EXHIBIT 105 FERTILITY SUPPLEMENTS MARKET IN US 2021-2027 ($ MILLION)
  • EXHIBIT 106 FACTORS DRIVING FERTILITY SUPPLEMENTS MARKET IN CANADA
  • EXHIBIT 107 FERTILITY SUPPLEMENTS MARKET IN CANADA 2021-2027 ($ MILLION)
  • EXHIBIT 108 APAC FERTILITY SUPPLEMENTS MARKET: KEY COUNTRIES (2021)
  • EXHIBIT 109 GLOBAL FERTILITY SUPPLEMENTS MARKET IN APAC: INCREMENTAL GROWTH & ABSOLUTE GROWTH
  • EXHIBIT 110 APAC FERTILITY SUPPLEMENTS MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 111 INCREMENTAL GROWTH IN APAC 2021 & 2027
  • EXHIBIT 112 JAPAN PROJECTED & ESTIMATED BIRTHS RATE PER WOMAN 2015-2022
  • EXHIBIT 113 FERTILITY SUPPLEMENTS MARKET IN JAPAN 2021-2027 ($ MILLION)
  • EXHIBIT 114 FERTILITY SUPPLEMENTS MARKET CHINA 2021-2027 ($ MILLION)
  • EXHIBIT 115 INFERTILE COUPLES BY AGE GROUP (MEN & WOMEN IN 2020)
  • EXHIBIT 116 FERTILITY SUPPLEMENTS MARKET IN INDIA 2021-2027 ($ MILLION)
  • EXHIBIT 117 FERTILITY SUPPLEMENTS MARKET IN SOUTH KOREA 2021-2027 ($ MILLION)
  • EXHIBIT 118 AUSTRALIA PROJECTED & ESTIMATED FERTILITY RATE 2015-2022 (BIRTH RATE PER WOMAN)
  • EXHIBIT 119 AUSTRALIAN GOVERNMENT POLICIES & PROGRAMS AND STRATEGIES & PLANS (AS OF MAY 31, 2022)
  • EXHIBIT 120 FERTILITY SUPPLEMENTS MARKET IN AUSTRALIA 2021-2027 ($ MILLION)
  • EXHIBIT 121 LATIN AMERICA FERTILITY SUPPLEMENTS MARKET: KEY COUNTRIES 2020
  • EXHIBIT 122 GLOBAL FERTILITY SUPPLEMENTS MARKET IN LATIN AMERICA: INCREMENTAL GROWTH & ABSOLUTE GROWTH
  • EXHIBIT 123 LATIN AMERICA FERTILITY SUPPLEMENTS MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 124 INCREMENTAL GROWTH IN LATIN AMERICA 2021 & 2027
  • EXHIBIT 125 FERTILITY SUPPLEMENTS MARKET IN BRAZIL 2021-2027 ($ MILLION)
  • EXHIBIT 126 FERTILITY SUPPLEMENTS MARKET IN MEXICO 2021-2027 ($ MILLION)
  • EXHIBIT 127 ARGENTINA FERTILITY RATE BY AGE GROUP IN 2020 (BIRTHS PER 1,000 WOMEN)
  • EXHIBIT 128 FERTILITY SUPPLEMENTS MARKET IN ARGENTINA 2021-2027 ($ MILLION)
  • EXHIBIT 129 GLOBAL FERTILITY SUPPLEMENTS MARKET IN MIDDLE EAST & AFRICA: INCREMENTAL GROWTH & ABSOLUTE GROWTH
  • EXHIBIT 130 MIDDLE EAST & AFRICA FERTILITY SUPPLEMENTS MARKET: KEY COUNTRIES (2021)
  • EXHIBIT 131 MIDDLE EAST & AFRICA FERTILITY SUPPLEMENTS MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 132 INCREMENTAL GROWTH IN MIDDLE EAST & AFRICA 2021 & 2027
  • EXHIBIT 133 FERTILITY SUPPLEMENTS MARKET IN TURKEY 2021-2027 ($ MILLION)
  • EXHIBIT 134 FERTILITY SUPPLEMENTS MARKET IN SAUDI ARABIA 2021-2027 ($ MILLION)
  • EXHIBIT 135 FERTILITY SUPPLEMENTS MARKET IN SOUTH AFRICA 2021-2027 ($ MILLION)
  • EXHIBIT 136 FERTILITY SUPPLEMENTS MARKET IN THE UAE 2021-2027 ($ MILLION)
  • EXHIBIT 137 VENDORS OFFERING FERTILITY SUPPLEMENTS VENDORS: MARKET DOMINANCE ANALYSIS
  • EXHIBIT 138 VENDORS OFFERING FERTILITY SUPPLEMENTS: CAPABILITIES & EXPERTISE ASSESSMENT

LIST OF TABLES

  • TABLE 1 KEY CAVEATS
  • TABLE 2 CURRENCY CONVERSION 2015-2021
  • TABLE 3 FERTILITY SUPPLEMENTS USED INGREDIENT FORM OUTCOMES & DOSAGE
  • TABLE 4 TOTAL FERTILITY RATE BY REGION & DEVELOPMENT GROUP, PROJECTION & ESTIMATES 1990-2030
  • TABLE 5 GLOBAL NATURAL FORM FERTILITY SUPPLEMENTS MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
  • TABLE 6 GLOBAL NATURAL FORM FERTILITY SUPPLEMENTS MARKET BY GEOGRAPHY 2021-2027 (%)
  • TABLE 7 BLEND FERTILITY SUPPLEMENT PRODUCTS
  • TABLE 8 GLOBAL SYNTHETIC & BLEND FERTILITY SUPPLEMENTS MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
  • TABLE 9 GLOBAL SYNTHETIC & BLEND FERTILITY SUPPLEMENTS MARKET BY GEOGRAPHY 2021-2027 (%)
  • TABLE 10 FERTILITY SUPPLEMENT PRODUCTS AVAILABLE AS CAPSULES
  • TABLE 11 GLOBAL CAPSULE FERTILITY SUPPLEMENTS MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
  • TABLE 12 GLOBAL CAPSULE FERTILITY SUPPLEMENTS MARKET BY GEOGRAPHY 2021-2027 (%)
  • TABLE 13 FERTILITY SUPPLEMENTS AVAILABLE AS TABLETS
  • TABLE 14 GLOBAL TABLET FERTILITY SUPPLEMENTS MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
  • TABLE 15 GLOBAL TABLET FERTILITY SUPPLEMENTS MARKET BY GEOGRAPHY 2021-2027 (%)
  • TABLE 16 GLOBAL SOFT GEL FERTILITY SUPPLEMENTS MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
  • TABLE 17 GLOBAL SOFT GEL FERTILITY SUPPLEMENTS MARKET BY GEOGRAPHY 2021-2027 (%)
  • TABLE 18 GLOBAL POWDER FERTILITY SUPPLEMENTS MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
  • TABLE 19 GLOBAL POWDER FERTILITY SUPPLEMENTS MARKET BY GEOGRAPHY 2021-2027 (%)
  • TABLE 20 GLOBAL LIQUID FERTILITY SUPPLEMENTS MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
  • TABLE 21 GLOBAL LIQUID FERTILITY SUPPLEMENTS MARKET BY GEOGRAPHY 2021-2027 (%)
  • TABLE 22 FERTILITY SUPPLEMENTS LAUNCHED FOR WOMEN
  • TABLE 23 GLOBAL WOMEN FERTILITY SUPPLEMENTS MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
  • TABLE 24 GLOBAL WOMEN FERTILITY SUPPLEMENTS MARKET BY GEOGRAPHY 2021-2027 (%)
  • TABLE 25 GLOBAL MEN FERTILITY SUPPLEMENTS MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
  • TABLE 26 GLOBAL MEN FERTILITY SUPPLEMENTS MARKET BY GEOGRAPHY 2021-2027 (%)
  • TABLE 27 GLOBAL OVER-THE-COUNTER(OTC) FERTILITY SUPPLEMENTS MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
  • TABLE 28 GLOBAL OVER-THE-COUNTER(OTC) FERTILITY SUPPLEMENTS MARKET BY GEOGRAPHY 2021-2027 (%)
  • TABLE 29 GLOBAL PRESCRIPTION FERTILITY SUPPLEMENTS MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
  • TABLE 30 GLOBAL PRESCRIPTION FERTILITY SUPPLEMENTS MARKET BY GEOGRAPHY 2021-2027 (%)
  • TABLE 31 EUROPE FERTILITY SUPPLEMENTS MARKET BY FORM 2021-2027 ($ MILLION)
  • TABLE 32 EUROPE FERTILITY SUPPLEMENTS MARKET BY FORM 2021-2027 (%)
  • TABLE 33 EUROPE FERTILITY SUPPLEMENTS MARKET BY TYPE 2021-2027 ($ MILLION)
  • TABLE 34 EUROPE FERTILITY SUPPLEMENTS MARKET BY TYPE 2021-2027 (%)
  • TABLE 35 EUROPE FERTILITY SUPPLEMENTS MARKET BY GENDER 2021-2027 ($ MILLION)
  • TABLE 36 EUROPE FERTILITY SUPPLEMENTS MARKET BY GENDER 2021-2027 (%)
  • TABLE 37 EUROPE FERTILITY SUPPLEMENTS MARKET BY PURCHASE CHANNEL 2021-2027 ($ MILLION)
  • TABLE 38 EUROPE FERTILITY SUPPLEMENTS MARKET BY PURCHASE CHANNEL 2021-2027 (%)
  • TABLE 39 NORTH AMERICA FERTILITY SUPPLEMENTS MARKET BY FORM 2021-2027 ($ MILLION)
  • TABLE 40 NORTH AMERICA FERTILITY SUPPLEMENTS MARKET BY FORM 2021-2027 (%)
  • TABLE 41 NORTH AMERICA FERTILITY SUPPLEMENTS MARKET BY TYPE 2021-2027 ($ MILLION)
  • TABLE 42 NORTH AMERICA FERTILITY SUPPLEMENTS MARKET BY TYPE 2021-2027 (%)
  • TABLE 43 NORTH AMERICA FERTILITY SUPPLEMENTS MARKET BY GENDER 2021-2027 ($ MILLION)
  • TABLE 44 NORTH AMERICA FERTILITY SUPPLEMENTS MARKET BY GENDER 2021-2027 (%)
  • TABLE 45 NORTH AMERICA FERTILITY SUPPLEMENTS MARKET BY PURCHASE CHANNEL 2021-2027 ($ MILLION)
  • TABLE 46 NORTH AMERICA FERTILITY SUPPLEMENTS MARKET BY PURCHASE CHANNEL 2021-2027 (%)
  • TABLE 47 FERTILITY RATE IN US BY AGE, FROM 1990 TO 2019
  • TABLE 48 GOVERNMENT INITIATIVES FOR FERTILITY CARE IN US
  • TABLE 49 PRESENCE OF PLAYERS IN FERTILITY SUPPLEMENTS MARKET IN US
  • TABLE 50 APAC FERTILITY SUPPLEMENTS MARKET BY FORM 2021-2027 ($ MILLION)
  • TABLE 51 APAC FERTILITY SUPPLEMENTS MARKET BY FORM 2021-2027 (%)
  • TABLE 52 APAC FERTILITY SUPPLEMENTS MARKET BY TYPE 2021-2027 ($ MILLION)
  • TABLE 53 APAC FERTILITY SUPPLEMENTS MARKET BY TYPE 2021-2027 (%)
  • TABLE 54 APAC FERTILITY SUPPLEMENTS MARKET BY GENDER 2021-2027 ($ MILLION)
  • TABLE 55 APAC FERTILITY SUPPLEMENTS MARKET BY GENDER 2021-2027 (%)
  • TABLE 56 APAC FERTILITY SUPPLEMENTS MARKET BY PURCHASE CHANNEL 2021-2027 ($ MILLION)
  • TABLE 57 APAC FERTILITY SUPPLEMENTS MARKET BY PURCHASE CHANNEL 2021-2027 (%)
  • TABLE 58 LATIN AMERICA FERTILITY SUPPLEMENTS MARKET BY FORM 2021-2027 ($ MILLION)
  • TABLE 59 LATIN AMERICA FERTILITY SUPPLEMENTS MARKET BY FORM 2021-2027 (%)
  • TABLE 60 LATIN AMERICA FERTILITY SUPPLEMENTS MARKET BY TYPE 2021-2027 ($ MILLION)
  • TABLE 61 LATIN AMERICA FERTILITY SUPPLEMENTS MARKET BY TYPE 2021-2027 (%)
  • TABLE 62 LATIN AMERICA FERTILITY SUPPLEMENTS MARKET BY GENDER 2021-2027 ($ MILLION)
  • TABLE 63 LATIN AMERICA FERTILITY SUPPLEMENTS MARKET BY GENDER 2021-2027 (%)
  • TABLE 64 LATIN AMERICA FERTILITY SUPPLEMENTS MARKET BY PURCHASE CHANNEL 2021-2027 ($ MILLION)
  • TABLE 65 LATIN AMERICA FERTILITY SUPPLEMENTS MARKET BY PURCHASE CHANNEL 2021-2027 (%)
  • TABLE 66 MIDDLE EAST & AFRICA FERTILITY SUPPLEMENTS MARKET BY FORM 2021-2027 ($ MILLION)
  • TABLE 67 MIDDLE EAST & AFRICA FERTILITY SUPPLEMENTS MARKET BY FORM 2021-2027 (%)
  • TABLE 68 MIDDLE EAST & AFRICA FERTILITY SUPPLEMENTS MARKET BY TYPE 2021-2027 ($ MILLION)
  • TABLE 69 MIDDLE EAST & AFRICA FERTILITY SUPPLEMENTS MARKET BY TYPE 2021-2027 (%)
  • TABLE 70 MIDDLE EAST & AFRICA FERTILITY SUPPLEMENTS MARKET BY GENDER 2021-2027 ($ MILLION)
  • TABLE 71 MIDDLE EAST & AFRICA FERTILITY SUPPLEMENTS MARKET BY GENDER 2021-2027 (%)
  • TABLE 72 MIDDLE EAST & AFRICA FERTILITY SUPPLEMENTS MARKET BY PURCHASE CHANNEL 2021-2027 ($ MILLION)
  • TABLE 73 MIDDLE EAST & AFRICA FERTILITY SUPPLEMENTS MARKET BY PURCHASE CHANNEL 2021-2027 (%)
  • TABLE 74 COAST SCIENCE: MAJOR PRODUCT OFFERINGS
  • TABLE 75 EXELTIS USA: MAJOR PRODUCT OFFERINGS
  • TABLE 76 FAIRHAVEN HEALTH: MAJOR PRODUCT OFFERINGS
  • TABLE 77 LENUS PHARMA GESMBH: MAJOR PRODUCT OFFERINGS
  • TABLE 78 VITABIOTICS LTD.: MAJOR PRODUCT OFFERINGS
  • TABLE 79 ADVACARE PHARMA: MAJOR PRODUCT OFFERINGS
  • TABLE 80 BAYER AG: MAJOR PRODUCT OFFERINGS
  • TABLE 81 BELI: MAJOR PRODUCT OFFERINGS
  • TABLE 82 CADI - CAMBRIDGE DIAGNOSTIC IMAGING: MAJOR PRODUCT OFFERINGS
  • TABLE 83 CARLSON LABS: MAJOR PRODUCT OFFERINGS
  • TABLE 84 DCMG LABORATORIES: MAJOR PRODUCT OFFERINGS
  • TABLE 85 ELAN HEALTHCARE: MAJOR PRODUCT OFFERINGS
  • TABLE 86 EU NATURAL: MAJOR PRODUCT OFFERINGS
  • TABLE 87 FERMENTA BIOTECH: MAJOR PRODUCT OFFERINGS
  • TABLE 88 FULLWELL: MAJOR PRODUCT OFFERINGS
  • TABLE 89 HERA: MAJOR PRODUCT OFFERINGS
  • TABLE 90 INOVA PHARMACEUTICALS (PTY) LTD.: MAJOR PRODUCT OFFERINGS
  • TABLE 91 LABORATORIOS FERTYPHARM S.L.: MAJOR PRODUCT OFFERINGS
  • TABLE 92 LIFE EXTENSION: MAJOR PRODUCT OFFERINGS
  • TABLE 93 NESTLE: MAJOR PRODUCT OFFERINGS
  • TABLE 94 NATURE'S CRAFT: MAJOR PRODUCT OFFERINGS
  • TABLE 95 NUTRA BUSINESS: MAJOR PRODUCT OFFERINGS
  • TABLE 96 NUA FERTILITY: MAJOR PRODUCT OFFERINGS
  • TABLE 97 OCEAN HEALTHCARE: MAJOR PRODUCT OFFERINGS
  • TABLE 98 ORTHOMOL: MAJOR PRODUCT OFFERINGS
  • TABLE 99 OVATERRA: MAJOR PRODUCT OFFERINGS
  • TABLE 100 PRAGATI BIOCARE PVT. LTD.: MAJOR PRODUCT OFFERINGS
  • TABLE 101 PREMAMA: MAJOR PRODUCT OFFERINGS
  • TABLE 102 PURITAN'S PRIDE: MAJOR PRODUCT OFFERINGS
  • TABLE 103 RITUAL: MAJOR PRODUCT OFFERINGS
  • TABLE 104 RENOVA NUTRITION: MAJOR PRODUCT OFFERINGS
  • TABLE 105 SUPPLEMENA: MAJOR PRODUCT OFFERINGS
  • TABLE 106 SEEKING HEALTH: MAJOR PRODUCT OFFERINGS
  • TABLE 107 TTK: MAJOR PRODUCT OFFERINGS
  • TABLE 108 THORNE: MAJOR PRODUCT OFFERINGS
  • TABLE 109 WELLBEING NUTRITION: MAJOR PRODUCT OFFERINGS
  • TABLE 110 ZENITH NUTRITION: MAJOR PRODUCT OFFERINGS
  • TABLE 111 GLOBAL FERTILITY SUPPLEMENTS MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
  • TABLE 112 GLOBAL FERTILITY SUPPLEMENTS MARKET BY GEOGRAPHY 2021-2027 (%)
  • TABLE 113 GLOBAL FERTILITY SUPPLEMENTS MARKET BY FORM 2021-2027 ($ MILLION)
  • TABLE 114 GLOBAL FERTILITY SUPPLEMENTS MARKET BY FORM 2021-2027 (%)
  • TABLE 115 GLOBAL FERTILITY SUPPLEMENTS MARKET BY TYPE 2021-2027 ($ MILLION)
  • TABLE 116 GLOBAL FERTILITY SUPPLEMENTS MARKET BY TYPE 2021-2027 (%)
  • TABLE 117 GLOBAL FERTILITY SUPPLEMENTS MARKET BY GENDER 2021-2027 ($ MILLION)
  • TABLE 118 GLOBAL FERTILITY SUPPLEMENTS MARKET BY GENDER 2021-2027 (%)
  • TABLE 119 GLOBAL FERTILITY SUPPLEMENTS MARKET BY PURCHASE CHANNEL 2021-2027 ($ MILLION)
  • TABLE 120 GLOBAL FERTILITY SUPPLEMENTS MARKET BY GEOGRAPHY 2021-2027 (%)
  • TABLE 121 GLOBAL NATURAL FERTILITY SUPPLEMENTS MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
  • TABLE 122 NATURAL FERTILITY SUPPLEMENTS MARKET BY GEOGRAPHY 2021-2027 (%)
  • TABLE 123 GLOBAL SYNTHETIC & BLEND FERTILITY SUPPLEMENTS MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
  • TABLE 124 SYNTHETIC & BLEND FERTILITY SUPPLEMENTS MARKET BY GEOGRAPHY 2021-2027 (%)
  • TABLE 125 GLOBAL CAPSULE FERTILITY SUPPLEMENTS MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
  • TABLE 126 CAPSULE FERTILITY SUPPLEMENTS MARKET BY GEOGRAPHY 2021-2027 (%)
  • TABLE 127 GLOBAL TABLET FERTILITY SUPPLEMENTS MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
  • TABLE 128 GLOBAL TABLET FERTILITY SUPPLEMENTS MARKET BY GEOGRAPHY 2021-2027 (%)
  • TABLE 129 GLOBAL SOFT GEL FERTILITY SUPPLEMENTS MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
  • TABLE 130 GLOBAL SOFT GEL FERTILITY SUPPLEMENTS MARKET BY GEOGRAPHY 2021-2027 (%)
  • TABLE 131 GLOBAL POWDER FERTILITY SUPPLEMENTS MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
  • TABLE 132 GLOBAL POWDER FERTILITY SUPPLEMENTS MARKET BY GEOGRAPHY 2021-2027 (%)
  • TABLE 133 GLOBAL LIQUID FERTILITY SUPPLEMENTS MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
  • TABLE 134 GLOBAL LIQUID FERTILITY SUPPLEMENTS MARKET BY GEOGRAPHY 2021-2027 (%)
  • TABLE 135 GLOBAL WOMEN FERTILITY SUPPLEMENTS MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
  • TABLE 136 GLOBAL WOMEN FERTILITY SUPPLEMENTS MARKET BY GEOGRAPHY 2021-2027 (%)
  • TABLE 137 GLOBAL MEN FERTILITY SUPPLEMENTS MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
  • TABLE 138 GLOBAL MEN FERTILITY SUPPLEMENTS MARKET BY GEOGRAPHY 2021-2027 (%)
  • TABLE 139 GLOBAL OTC FERTILITY SUPPLEMENTS MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
  • TABLE 140 GLOBAL OTC FERTILITY SUPPLEMENTS MARKET BY GEOGRAPHY 2021-2027 (%)
  • TABLE 141 GLOBAL PRESCRIPTION FERTILITY SUPPLEMENTS MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
  • TABLE 142 GLOBAL PRESCRIPTION FERTILITY SUPPLEMENTS MARKET BY GEOGRAPHY 2021-2027 (%)
目次
Product Code: ARZ221205

The global fertility supplements market is expected to grow at a CAGR of 7.68% during 2022-2027.

MARKET OUTLOOK

The global industry will likely grow healthy due to attractive long-term growth from favorable demographic and social/cultural shifts. Fertility supplements are a growing industry with high opportunities for manufacturers, especially for vendors offering fertility supplement solutions that male and female consumers widely use. Factors like growing awareness regarding fertility health, increasing advanced maternal age population (women) in developed and emerging markets, rapidly increasing population of infertile couples worldwide, and awareness of infertility issues among the global adult population are boosting the fertility supplements market.

The fertility supplements are chemically manufactured solutions that improve fertility levels in men and women. Fertility supplements contain vitamins, minerals, hormones, antioxidants, and other ingredients that can boost fertility. In recent years, fertility supplements containing plant-derived ingredients have been in high demand. For men, fertility supplements help to increase sperm motility, count, and testosterone level. On another side for women, fertility supplements help to elevate the estrogen level and improve the menstrual cycle. Fertility supplements deliver significant benefits for improving the fertility level, such as it helps to build hormones that further support reproductive procedures, positively influencing the fertility supplements market growth.

MARKET TRENDS & DRIVERS

Advancement, Research, And Credibility In Fertility Supplements Propel Interest In A Dynamic Array Of Fertility Supplements

  • Fertility supplements market players are launching synergistic fertility blend brands and pushing for industry expansion from single-ingredients products. Some clinical trial studies reveal which fertility ingredients are the best validated, which expected the fertility industry to offer and deliver significant opportunities for credible product brands. Natural fertility supplement solutions reduced the risk of side effects, one of the significant factors that recently drove the demand for natural/plant-derived fertility supplements.

Globally, The Increasing Infertility Prevalence Drive The High Development In Fertility Care.

  • Across the world, millions of couples suffer from this concern and demand for fertility treatments. Due to rising infertility prevalence, the demand for care also significantly increased. In developing countries, the significant prevalence of infertility drives high market growth; for instance, India is one of the rapidly growing markets for fertility supplements. The presence of industry players and a high patient demography pool gives market expansion access and fuels the fertility supplements market growth in the region.
  • Government support and public initiatives to increase awareness regarding the advancement in fertility supplements also play a significant role in the industry. The changing lifestyle of people and delayed pregnancies is a major factor that requires fertility care and support. The increasing prevalence of adolescent pregnancy globally and the increasing consequences of conceiving at an advanced maternal age also support the demand for fertility support solutions.

SEGMENTATION ANALYSIS

INSIGHTS BY FORM

The global fertility supplements market by form is segmented into natural and synthetic & blends. In 2021, the natural segment accounted for a 56.62% share of the global supplements market. Recently, the natural supplement products such as plant-derived solutions have been highly demanded by customers. Due to the increasing attention towards natural fertility care, there is a significant demand for natural ingredient-based fertility supplements by people. Further, the trend towards natural healthcare solutions and the rising research and studies on the effectiveness of plant-derived solutions on fertility health is increasing and gaining the attention of researchers and professionals. Such factors drive significant growth opportunities for the market. The global fertility supplements market by natural form segment is growing at a CAGR of 7.12% during the forecast period.

The synthetic & blend segment accounted for a 43.38% share of the global fertility supplements market. Synthetic fertility supplement products are manufactured through zinc, folic acid, vitamin C & Vitamin B6, Myo-inositol, CoQ10, and others. Zinc is a majorly adopted synthetic ingredient used in male fertility supplement solutions. It is one of the most addressed and abundant trace elements in human beings that is not stored in the body and demand regular dietary intake. The physiological role of zinc in men's health is to improve the quality of sperm, germination, and fertilization.

Segmentation by Form

  • Natural
  • Synthetic & Blend

INSIGHTS BY TYPE

In 2021, the capsule segment accounted for a market share of 45.87% in the global fertility supplements market. Fertility supplements are available in various forms, in which the capsule segment accounted higher industry share and shows dominance over the other product segment. Fertility supplements are a mixture of various ingredients that require stability after the packaging. Alternatively, capsules are easy to swallow for patients and fill for manufacturers. Hard gelatin capsules and soft gelatin capsules are two types of capsule forms used to fill fertility supplements.

Behind the capsule segment, the tablet segment accounted for 26.97% industry share. It is expected to grow with a 7.39% CAGR from 2021 to 2027. The tablets are somewhat working like capsules. It's the most common type of pill that is safe, inexpensive, and effective for oral medications. Fertility supplements are primely available for oral dosage, giving high demand for tablet form in the fertility supplement solution.

Segmentation by Type

  • Capsule
  • Tablet
  • Soft Gel
  • Powder
  • Liquid

INSIGHTS BY GENDER

The global fertility supplements market by gender is segmented into men and women. In 2021, the women segment accounted for 63.77% of the global fertility supplements market share. According to National Center for Health Statistics, many women experience fertility issues over their reproductive years. In the US, the prevalence of impaired fecundity problems, such as getting pregnant and carrying a pregnancy to term, is around 12.1% in 2021. Further, the rapid decline in the fertility rate in women due to hormonal disorders and other reproductive system disorders, such as failure to ovulate, endometriosis, implantation failure, and uterine fibroids, are key growth drivers for industry growth.

Segmentation by Gender

  • Women
  • Men

INSIGHTS BY PURCHASE CHANNEL

The over-the-counter (OTC) segment accounted for a 67.51% share of the global fertility supplements market and dominated the prescription segment. Globally, millions of people suffer from infertility issues and looking for convenient and cost-effective treatments, and fertility supplements are one of the leading care solutions. Fertility supplements are cost-effective and available on OTC channels, giving easy access rather than consulting by professionals and physicians. The increasing awareness and knowledge in developed countries about self-medication for fertility care push the significant population towards OTC channels that drive segmental growth.

Segmentation by Purchase Channels

  • Over-the-counter (OTC)
  • Prescription

GEOGRAPHICAL ANALYSIS

Europe is a highly dominating global fertility supplements market region, valued at USD 610.79 million in 2021. Due to the higher awareness level about fertility care and fertility supplements, high expenditure and acceptance of fertility-boosting solutions are expected to fuel the region's market growth. In addition, the increasing infertility prevalence, changing lifestyle, delayed pregnancy, and increasing maternal age are some factors that led to the increasing infertility issues that drive the high demand for fertility care and accelerate the industry growth. In 2021, Italy accounted for 21.70% of the higher industry share and stood as the leading country in Europe. The significant industry growth contributing factors addressed in Italy are the significant development and higher acceptance of fertility care services.

The fertility supplements market in North America is expected to reach USD 14.63 million by 2027. The region is a developed industry for fertility supplements due to the higher knowledge & acceptance of fertility care solutions. The government initiatives for fertility care in the region, the new products launched by the leading industry players, and the decline in fertility rate and birth rate are the factors that significantly drive the industry growth. The increasing prevalence of infertility drives the demand for fertility supplement solutions.

APAC is one of the emerging and rapidly growing markets due to the higher patient population. The increasing prevalence of infertility and the decline in birth rate pushed people to fertility supplements as primary care. In APAC, China and India are growing countries for fertility supplements. The presence of a high number of emerging industry players and new start-ups is delivering new products that will drive industry growth.

Segmentation by Geography

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • Italy
    • Spain
    • France
    • UK
  • APAC
    • Japan
    • China
    • South Korea
    • India
    • Australia
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • South Africa
    • UAE

VENDOR LANDSCAPE

The global fertility supplements market has been rapidly growing in recent years due to the rise in the prevalence of infertility among men and women. The industry includes leading, emerging, and start-up companies are trying to achieve significant growth in various ways. Several global and regional players in the fertility supplements market offer various fertility supplements in natural, synthetic, and blended ingredients. Further, the launch of new start-ups and product launches influence competitiveness in the industry. Most vendors are increasingly focused on marketing and extending their product portfolio to gain a competitive edge over other industry players. Rapid fertility supplement advances in the industry have significantly impacted the products' growth.

Recent Product Launches In The Global Fertility Supplements Market

  • In 2022, Wellbeing Nutrition Indian, the fastest-growing plant-based nutrition company, is anticipated to launch a "SLOW" nutraceutical product portfolio.
  • Nua fertility is one of the world-class fertility brands focused on innovation and delivery of world-class fertility products. In 2020, the company launched the fertility supplement "NuaBiome' for women.
  • In 2020, CaDi, the well-known company for customized nutraceutical programs, launched the powerful personalized fertility supplement Lycofertilic -DHA Omega 3.

Key Vendors

  • Coast Science
  • Exeltis USA
  • Fairhaven Health
  • LENUS Pharma GesmbH
  • Vitabiotics Ltd.

Other Prominent Vendors

  • AdvaCare Pharma
  • Bayer Ag
  • Beli
  • CaDi- Cambridge Diagnostic Imaging
  • Carlson Labs
  • DCMG Laboratories
  • Elan Healthcare
  • Eu Natural
  • Fermenta Biotech
  • FullWell
  • Hera (HeraNow)
  • iNova Pharmaceuticals (Pty) Ltd.
  • Laboratorios Fertypharm S.L.
  • Life Extension
  • Nestle
  • Nature's Craft
  • Nutra Business
  • Nua Fertility
  • Ocean Healthcare
  • Orthomol
  • Ovaterra
  • Pragati Biocare Pvt. Ltd.
  • Premama
  • Puritan's Pride
  • Ritual
  • Renova Nutrition
  • Supplemena
  • Seeking Health
  • TTK
  • Thorne
  • Wellbeing Nutrition
  • Zenith Nutrition

KEY QUESTIONS ANSWERED

  • 1. How big is the fertility supplements market?
  • 2. What is the growth rate of the global fertility supplements market?
  • 3. What are the growing trends in the global fertility supplements market?
  • 4. How big is the North American fertility supplements market?
  • 5. Who are the key players in the global fertility supplements market growth?
  • 6. Which region has the most extensive fertility supplements market share globally?

TABLE OF CONTENTS

1 RESEARCH METHODOLOGY

2 RESEARCH OBJECTIVES

3 RESEARCH PROCESS

4 SCOPE & COVERAGE

  • 4.1 MARKET DEFINITION
    • 4.1.1 INCLUSIONS
    • 4.1.2 EXCLUSIONS
    • 4.1.3 MARKET ESTIMATION CAVEATS
  • 4.2 BASE YEAR
  • 4.3 SCOPE OF THE STUDY
    • 4.3.1 MARKET SEGMENTATION BY FORM
    • 4.3.2 MARKET SEGMENTATION BY TYPE
    • 4.3.3 MARKET SEGMENTATION BY GENDER
    • 4.3.4 MARKET SEGMENTATION BY PURCHASE CHANNEL
    • 4.3.5 MARKET SEGMENTATION BY GEOGRAPHY

5 REPORT ASSUMPTIONS & CAVEATS

  • 5.1 KEY CAVEATS
  • 5.2 CURRENCY CONVERSION
  • 5.3 MARKET DERIVATION

6 MARKET AT A GLANCE

7 INTRODUCTION

  • 7.1 OVERVIEW

8 PREMIUM INSIGHTS

  • 8.1 OVERVIEW

9 MARKET OPPORTUNITIES & TRENDS

  • 9.1 ADVANCES, RESEARCH, & CREDIBILITY IN FERTILITY SUPPLEMENTS
  • 9.2 INCREASE IN PRODUCT LAUNCHES
  • 9.3 FOCUS ON NATURAL FERTILITY SUPPLEMENTS

10 MARKET GROWTH ENABLERS

  • 10.1 INCREASE IN PREVALENCE OF INFERTILITY RATE
  • 10.2 INCREASE IN GOVERNMENT & PUBLIC INITIATIVES FOR FERTILITY AWARENESS
  • 10.3 TREND OF DELAYED PREGNANCIES

11 MARKET RESTRAINTS

  • 11.1 LACK OF AWARENESS & LOW ACCESS TO FERTILITY TREATMENTS IN EMERGING MARKETS
  • 11.2 SIDE EFFECTS RELATED TO FERTILITY SUPPLEMENTS
  • 11.3 PRESENCE OF ALTERNATIVES TO FERTILITY SUPPLEMENTS

12 MARKET LANDSCAPE

  • 12.1 MARKET OVERVIEW
    • 12.1.1 INSIGHT BY GEOGRAPHY
    • 12.1.2 INSIGHT BY PURCHASE CHANNEL
    • 12.1.3 INSIGHT BY FORM
    • 12.1.4 INSIGHT BY TYPE
    • 12.1.5 INSIGHTS BY GENDER
  • 12.2 MARKET SIZE & FORECAST
  • 12.3 FIVE FORCES ANALYSIS
    • 12.3.1 THREAT OF NEW ENTRANTS
    • 12.3.2 BARGAINING POWER OF SUPPLIERS
    • 12.3.3 BARGAINING POWER OF BUYERS
    • 12.3.4 THREAT OF SUBSTITUTES
    • 12.3.5 COMPETITIVE RIVALRY

13 FORM

  • 13.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 13.2 MARKET OVERVIEW
  • 13.3 NATURAL
    • 13.3.1 MARKET OVERVIEW
    • 13.3.2 MARKET SIZE & FORECAST
    • 13.3.3 MARKET BY GEOGRAPHY
  • 13.4 SYNTHETIC & BLEND
    • 13.4.1 MARKET OVERVIEW
    • 13.4.2 MARKET SIZE & FORECAST
    • 13.4.3 MARKET BY GEOGRAPHY

14 TYPE

  • 14.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 14.2 MARKET OVERVIEW
  • 14.3 CAPSULE
    • 14.3.1 MARKET OVERVIEW
    • 14.3.2 MARKET SIZE & FORECAST
    • 14.3.3 MARKET BY GEOGRAPHY
  • 14.4 TABLET
    • 14.4.1 MARKET OVERVIEW
    • 14.4.2 MARKET SIZE & FORECAST
    • 14.4.3 MARKET BY GEOGRAPHY
  • 14.5 SOFT GEL
    • 14.5.1 MARKET OVERVIEW
    • 14.5.2 MARKET SIZE & FORECAST
    • 14.5.3 MARKET BY GEOGRAPHY
  • 14.6 POWDER
    • 14.6.1 MARKET OVERVIEW
    • 14.6.2 MARKET SIZE & FORECAST
    • 14.6.3 MARKET BY GEOGRAPHY
  • 14.7 LIQUID
    • 14.7.1 MARKET OVERVIEW
    • 14.7.2 MARKET SIZE & FORECAST
    • 14.7.3 MARKET BY GEOGRAPHY

15 GENDER

  • 15.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 15.2 MARKET OVERVIEW
  • 15.3 WOMEN
    • 15.3.1 MARKET OVERVIEW
    • 15.3.2 MARKET SIZE & FORECAST
    • 15.3.3 MARKET BY GEOGRAPHY
  • 15.4 MEN
    • 15.4.1 MARKET OVERVIEW
    • 15.4.2 MARKET SIZE & FORECAST
    • 15.4.3 MARKET BY GEOGRAPHY

16 PURCHASE CHANNEL

  • 16.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 16.2 MARKET OVERVIEW
  • 16.3 OVER-THE-COUNTER (OTC)
    • 16.3.1 MARKET OVERVIEW
    • 16.3.2 MARKET SIZE & FORECAST
    • 16.3.3 MARKET BY GEOGRAPHY
  • 16.4 PRESCRIPTION
    • 16.4.1 MARKET OVERVIEW
    • 16.4.2 MARKET SIZE & FORECAST
    • 16.4.3 MARKET BY GEOGRAPHY

17 GEOGRAPHY

  • 17.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 17.2 GEOGRAPHIC OVERVIEW

18 EUROPE

  • 18.1 MARKET OVERVIEW
  • 18.2 MARKET SIZE & FORECAST
  • 18.3 FORM
    • 18.3.1 MARKET SIZE & FORECAST
  • 18.4 TYPE
    • 18.4.1 MARKET SIZE & FORECAST
  • 18.5 GENDER
    • 18.5.1 MARKET SIZE & FORECAST
  • 18.6 PURCHASE CHANNEL
    • 18.6.1 MARKET SIZE & FORECAST
  • 18.7 KEY COUNTRIES
    • 18.7.1 ITALY: MARKET SIZE & FORECAST
    • 18.7.2 SPAIN: MARKET SIZE & FORECAST
    • 18.7.3 GERMANY: MARKET SIZE & FORECAST
    • 18.7.4 UK: MARKET SIZE & FORECAST
    • 18.7.5 FRANCE: MARKET SIZE & FORECAST

19 NORTH AMERICA

  • 19.1 MARKET OVERVIEW
  • 19.2 MARKET SIZE & FORECAST
  • 19.3 FORM
    • 19.3.1 MARKET SIZE & FORECAST
  • 19.4 TYPE
    • 19.4.1 MARKET SIZE & FORECAST
  • 19.5 GENDER
    • 19.5.1 MARKET SIZE & FORECAST
  • 19.6 PURCHASE CHANNEL
    • 19.6.1 MARKET SIZE & FORECAST
  • 19.7 KEY COUNTRIES
    • 19.7.1 US: MARKET SIZE & FORECAST
    • 19.7.2 CANADA: MARKET SIZE & FORECAST

20 APAC

  • 20.1 MARKET OVERVIEW
  • 20.2 MARKET SIZE & FORECAST
  • 20.3 FORM
    • 20.3.1 MARKET SIZE & FORECAST
  • 20.4 TYPE
    • 20.4.1 MARKET SIZE & FORECAST
  • 20.5 GENDER
    • 20.5.1 MARKET SIZE & FORECAST
  • 20.6 PURCHASE CHANNEL
    • 20.6.1 MARKET SIZE & FORECAST
  • 20.7 KEY COUNTRIES
    • 20.7.1 JAPAN: MARKET SIZE & FORECAST
    • 20.7.2 CHINA: MARKET SIZE & FORECAST
    • 20.7.3 INDIA: MARKET SIZE & FORECAST
    • 20.7.4 SOUTH KOREA: MARKET SIZE & FORECAST
    • 20.7.5 AUSTRALIA: MARKET SIZE & FORECAST

21 LATIN AMERICA

  • 21.1 MARKET OVERVIEW
  • 21.2 MARKET SIZE & FORECAST
  • 21.3 FORM
    • 21.3.1 MARKET SIZE & FORECAST
  • 21.4 TYPE
    • 21.4.1 MARKET SIZE & FORECAST
  • 21.5 GENDER
    • 21.5.1 MARKET SIZE & FORECAST
  • 21.6 PURCHASE CHANNEL
    • 21.6.1 MARKET SIZE & FORECAST
  • 21.7 KEY COUNTRIES
    • 21.7.1 BRAZIL: MARKET SIZE & FORECAST
    • 21.7.2 MEXICO: MARKET SIZE & FORECAST
    • 21.7.3 ARGENTINA: MARKET SIZE & FORECAST

22 MIDDLE EAST & AFRICA

  • 22.1 MARKET OVERVIEW
  • 22.2 MARKET SIZE & FORECAST
  • 22.3 FORM
    • 22.3.1 MARKET SIZE & FORECAST
  • 22.4 TYPE
    • 22.4.1 MARKET SIZE & FORECAST
  • 22.5 GENDER
    • 22.5.1 MARKET SIZE & FORECAST
  • 22.6 PURCHASE CHANNEL
    • 22.6.1 MARKET SIZE & FORECAST
  • 22.7 KEY COUNTRIES
    • 22.7.1 TURKEY: MARKET SIZE & FORECAST
    • 22.7.2 SAUDI ARABIA: MARKET SIZE & FORECAST
    • 22.7.3 SOUTH AFRICA: MARKET SIZE & FORECAST
    • 22.7.4 UAE: MARKET SIZE & FORECAST

23 COMPETITIVE LANDSCAPE

  • 23.1 COMPETITION OVERVIEW
  • 23.2 MARKET SHARE ANALYSIS
    • 23.2.1 COAST SCIENCE
    • 23.2.2 EXELTIS USA
    • 23.2.3 FAIRHAVEN HEALTH
    • 23.2.4 LENUS PHARMA GESMBH
    • 23.2.5 VITABIOTICS

24 KEY COMPANY PROFILES

  • 24.1 COAST SCIENCE
    • 24.1.1 BUSINESS OVERVIEW
    • 24.1.2 PRODUCT OFFERINGS
    • 24.1.3 KEY STRATEGIES
    • 24.1.4 KEY STRENGTHS
    • 24.1.5 KEY OPPORTUNITIES
  • 24.2 EXELTIS USA
    • 24.2.1 BUSINESS OVERVIEW
    • 24.2.2 PRODUCT OFFERINGS
    • 24.2.3 KEY STRATEGIES
    • 24.2.4 KEY STRENGTHS
    • 24.2.5 KEY OPPORTUNITIES
  • 24.3 FAIRHAVEN HEALTH
    • 24.3.1 BUSINESS OVERVIEW
    • 24.3.2 PRODUCT OFFERINGS
    • 24.3.3 KEY STRATEGIES
    • 24.3.4 KEY STRENGTHS
    • 24.3.5 KEY OPPORTUNITIES
  • 24.4 LENUS PHARMA GESMBH
    • 24.4.1 BUSINESS OVERVIEW
    • 24.4.2 PRODUCT OFFERINGS
    • 24.4.3 KEY STRATEGIES
    • 24.4.4 KEY STRENGTHS
    • 24.4.5 KEY OPPORTUNITIES
  • 24.5 VITABIOTICS
    • 24.5.1 BUSINESS OVERVIEW
    • 24.5.2 PRODUCT OFFERINGS
    • 24.5.3 KEY STRATEGIES
    • 24.5.4 KEY STRENGTHS
    • 24.5.5 KEY OPPORTUNITIES

25 OTHER PROMINENT VENDORS

  • 25.1 ADVACARE PHARMA
    • 25.1.1 BUSINESS OVERVIEW
    • 25.1.2 PRODUCT OFFERINGS
  • 25.2 BAYER AG
    • 25.2.1 BUSINESS OVERVIEW
    • 25.2.2 PRODUCT OFFERINGS
  • 25.3 BELI
    • 25.3.1 BUSINESS OVERVIEW
    • 25.3.2 PRODUCT OFFERINGS
  • 25.4 CADI - CAMBRIDGE DIAGNOSTIC IMAGING
    • 25.4.1 BUSINESS OVERVIEW
    • 25.4.2 PRODUCT OFFERINGS
  • 25.5 CARLSON LABS
    • 25.5.1 BUSINESS OVERVIEW
    • 25.5.2 PRODUCT OFFERINGS
  • 25.6 DCMG LABORATORIES
    • 25.6.1 BUSINESS OVERVIEW
    • 25.6.2 PRODUCT OFFERINGS
  • 25.7 ELAN HEALTHCARE
    • 25.7.1 BUSINESS OVERVIEW
    • 25.7.2 PRODUCT OFFERINGS
  • 25.8 EU NATURAL
    • 25.8.1 BUSINESS OVERVIEW
    • 25.8.2 PRODUCT OFFERINGS
  • 25.9 FERMENTA BIOTECH
    • 25.9.1 BUSINESS OVERVIEW
    • 25.9.2 PRODUCT OFFERINGS
  • 25.10 FULLWELL
    • 25.10.1 BUSINESS OVERVIEW
    • 25.10.2 PRODUCT OFFERINGS
  • 25.11 HERA (HERANOW)
    • 25.11.1 BUSINESS OVERVIEW
    • 25.11.2 PRODUCT OFFERINGS
  • 25.12 INOVA PHARMACEUTICALS (PTY) LTD.
    • 25.12.1 BUSINESS OVERVIEW
    • 25.12.2 PRODUCT OFFERINGS
  • 25.13 LABORATORIOS FERTYPHARM S.L.
    • 25.13.1 BUSINESS OVERVIEW
    • 25.13.2 PRODUCT OFFERINGS
  • 25.14 LIFE EXTENSION
    • 25.14.1 BUSINESS OVERVIEW
    • 25.14.2 PRODUCT OFFERINGS
  • 25.15 NESTLE
    • 25.15.1 BUSINESS OVERVIEW
    • 25.15.2 PRODUCT OFFERINGS
  • 25.16 NATURE'S CRAFT
    • 25.16.1 BUSINESS OVERVIEW
    • 25.16.2 PRODUCT OFFERINGS
  • 25.17 NUTRA BUSINESS
    • 25.17.1 BUSINESS OVERVIEW
    • 25.17.2 PRODUCT OFFERINGS
  • 25.18 NUA FERTILITY
    • 25.18.1 BUSINESS OVERVIEW
    • 25.18.2 PRODUCT OFFERINGS
  • 25.19 OCEAN HEALTHCARE
    • 25.19.1 BUSINESS OVERVIEW
    • 25.19.2 PRODUCT OFFERINGS
  • 25.20 ORTHOMOL
    • 25.20.1 BUSINESS OVERVIEW
    • 25.20.2 PRODUCT OFFERINGS
  • 25.21 OVATERRA
    • 25.21.1 BUSINESS OVERVIEW
    • 25.21.2 PRODUCT OFFERINGS
  • 25.22 PRAGATI BIOCARE PVT. LTD.
    • 25.22.1 BUSINESS OVERVIEW
    • 25.22.2 PRODUCT OFFERINGS
  • 25.23 PREMAMA
    • 25.23.1 BUSINESS OVERVIEW
    • 25.23.2 PRODUCT OFFERINGS
  • 25.24 PURITAN'S PRIDE
    • 25.24.1 BUSINESS OVERVIEW
    • 25.24.2 PRODUCT OFFERINGS
  • 25.25 RITUAL
    • 25.25.1 BUSINESS OVERVIEW
    • 25.25.2 PRODUCT OFFERINGS
  • 25.26 RENOVA NUTRITION
    • 25.26.1 BUSINESS OVERVIEW
    • 25.26.2 PRODUCT OFFERINGS
  • 25.27 SUPPLEMENA
    • 25.27.1 BUSINESS OVERVIEW
    • 25.27.2 PRODUCT OFFERINGS
  • 25.28 SEEKING HEALTH
    • 25.28.1 BUSINESS OVERVIEW
    • 25.28.2 PRODUCT OFFERINGS
  • 25.29 TTK
    • 25.29.1 BUSINESS OVERVIEW
    • 25.29.2 PRODUCT OFFERINGS
  • 25.30 THORNE
    • 25.30.1 BUSINESS OVERVIEW
    • 25.30.2 PRODUCT OFFERINGS
  • 25.31 WELLBEING NUTRITION
    • 25.31.1 BUSINESS OVERVIEW
    • 25.31.2 PRODUCT OFFERINGS
  • 25.32 ZENITH NUTRITION
    • 25.32.1 BUSINESS OVERVIEW
    • 25.32.2 PRODUCT OFFERINGS

26 REPORT SUMMARY

  • 26.1 KEY TAKEAWAYS
  • 26.2 STRATEGIC RECOMMENDATIONS

27 QUANTITATIVE SUMMARY

  • 27.1 MARKET BY GEOGRAPHY
  • 27.2 MARKET BY FORM
  • 27.3 MARKET BY TYPE
  • 27.4 MARKET BY GENDER
  • 27.5 MARKET BY PURCHASE CHANNEL
  • 27.6 FORM: MARKET BY GEOGRAPHY
    • 27.6.1 NATURAL: MARKET BY GEOGRAPHY
    • 27.6.2 SYNTHETIC & BLEND: MARKET BY GEOGRAPHY
  • 27.7 TYPE: MARKET BY GEOGRAPHY
    • 27.7.1 CAPSULE: MARKET BY GEOGRAPHY
    • 27.7.2 TABLET: MARKET BY GEOGRAPHY
    • 27.7.3 SOFT GEL: MARKET BY GEOGRAPHY
    • 27.7.4 POWDER: MARKET BY GEOGRAPHY
    • 27.7.5 LIQUID: MARKET BY GEOGRAPHY
  • 27.8 GENDER: MARKET BY GEOGRAPHY
    • 27.8.1 WOMEN: MARKET BY GEOGRAPHY
    • 27.8.2 MEN: MARKET BY GEOGRAPHY
  • 27.9 PURCHASE CHANNEL: MARKET BY GEOGRAPHY
    • 27.9.1 OTC: MARKET BY GEOGRAPHY
    • 27.9.2 PRESCRIPTION: MARKET BY GEOGRAPHY

28 APPENDIX

  • 28.1 ABBREVIATIONS